Results 31 to 40 of about 6,703,622 (155)

IgA mediated anti-glomerular basement membrane disease with associated circulating anti-neutrophil cytoplasm antibodies [PDF]

open access: yesJournal of Nephropathology
Anti-glomerular basement membrane (anti-GBM) disease is an aggressive small vessel vasculitis usually mediated by IgG autoantibodies. We describe the case of a 73-year-old male with rapidly progressive renal failure that was diagnosed with IgA mediated ...
Patricia Alves   +4 more
doaj   +1 more source

Seronegative Atypical Anti-Glomerular Basement Membrane Glomerulonephritis Associated With Thrombotic Microangiopathy: Case Report and Literature Analysis

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2023
Anti-glomerular basement membrane (GBM) antibody nephritis is defined by linear immunofluorescence staining of GBM by immunoglobulin G (IgG), typically associated with GBM rupture, fibrinoid necrosis, and crescent formation.
Sasmit Roy MD   +8 more
doaj   +1 more source

Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort

open access: yesFrontiers in Immunology, 2020
Background: Atypical cases of anti-glomerular basement membrane (GBM) disease had absent circulating antibodies but linear IgG deposits along GBM in the kidneys.
Cong-rong Shen   +25 more
doaj   +1 more source

Anti-Glomerular Basement Membrane Disease [PDF]

open access: yes, 2018
Anti–glomerular basement membrane (GBM) disease often presents with rapidly progressive glomerulonephritis with or without lung hemorrhage. It is rare to present with lung hemorrhage alone.
Kavita Gulati   +3 more
core   +1 more source

Heavy chain deposition disease presenting with raised anti-GBM antibody levels; a case report

open access: yesBMC Nephrology, 2020
Background Monoclonal immunoglobulin deposition disease (MIDD) is a rare condition accounting for
Michael Turner   +6 more
doaj   +1 more source

Co-injection of anti-HS antibodies during anti-GBM-induced glomerulonephritis induces a transient increase in albuminuria and decline in renal function.

open access: yes, 2021
Blood urea nitrogen (BUN) levels after (A) 2 hours, (B) 1 day and (C) 4 days. Urinary albumin concentration after 2 hours (D) and urinary albumin:creatinine ratios after (E) 1 day and (F) 4 days anti-GBM-induced glomerulonephritis.
Toin H. van Kuppevelt (10013111)   +8 more
core   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher   +7 more
wiley   +1 more source

A case of bizarre posttransplant anti-glomerular basement membrane disease

open access: yesCentral European Journal of Immunology, 2019
The non-collagenous (NC1) domain of 3 and 5 chains of type IV collagen are eminent targets of abnormal immune response in anti-glomerular basement membrane (anti-GBM) disease, which can be diagnosed by the presence of strong linear IgG staining along ...
Anna Olewicz-Gawlik   +9 more
doaj   +1 more source

Nephrotic syndrome due to minimal-change disease superimposed on anti-glomerular basement membrane antibody positive glomerulonephritis; a case report

open access: yesBMC Nephrology, 2020
Background The prognosis for renal function in anti-GBM glomerulonephritis (anti-GBM GN) is extremely poor, and when renal impairment progresses severely, it is difficult to expect improvement. In addition, it is also known that once the disease activity
Yuko Shibata   +13 more
doaj   +1 more source

Laboratory solution to diagnose and monitor atypical IgG4-mediated anti-GBM disease

open access: yesClinical Chemistry and Laboratory Medicine (CCLM)
Abstract Objectives Diagnosing atypical IgG4-mediated anti-glomerular basement membrane (anti-GBM) disease is challenging because conventional serological assays poorly detect IgG4 antibodies. Here we study which commercial assays are affected and we describe proof-of-concept of improved IgG4 ...
Joannes F M, Jacobs   +11 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy